Imaging with SPECT can identify brain trauma among NFL players.
Single photon emission computed tomography (SPECT) imaging detects brain damage among professional football players who sustained multiple head collisions during their playing careers, according to a study published in the Journal of Alzheimer's Disease.
Researchers from California and Pennsylvania sought to determine if low perfusion in specific brain images, observed with neuroimaging, could identify which subjects were football players and which were healthy controls.
The study included 161 retired and current NFL players and 124 healthy controls. All underwent medical examinations, neuropsychological tests, and perfusion neuroimaging with SPECT. Perfusion estimates of each scan were quantified using a standard atlas. The researchers hypothesized that hypoperfusion, particularly in the orbital frontal, anterior cingulate, anterior temporal, hippocampal, amygdala, insular, caudate, superior/mid occipital, and cerebellar sub-regions alone would reliably separate controls from NFL players.[[{"type":"media","view_mode":"media_crop","fid":"48437","attributes":{"alt":"NFL imaging","class":"media-image media-image-right","id":"media_crop_5614527324365","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5778","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 128px; width: 171px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©gualtiero boffi/Shutterstock.com","typeof":"foaf:Image"}}]]
that the NFL players showed lower cerebral perfusion on average in 36 brain regions. The NFL players were distinguished from controls with 90% sensitivity, 86% specificity, and 94% accuracy.
The researchers concluded that they could detect abnormally low perfusion on SPECT in professional NFL players, identifying traumatic brain injury in specific regions. “These same regions alone can distinguish this group from healthy subjects with high diagnostic accuracy,” they wrote.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.